Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Ceccarelli

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Annals of the Rheumatic Diseases|May 17, 2011
Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvementMirko Manetti, Serena Guiducci, Claudia Ceccarelli, et al.
Thyroid : Official Journal of the American Thyroid Association|January 13, 2006
RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentrationRossella Elisei, Cristina Romei, Maria Grazia Castagna, et al.
Clinical Endocrinology|March 3, 2009
Health outcomes of children fathered by patients treated with radioiodine for thyroid cancerJérôme-Philippe Garsi, Martin Schlumberger, Marcel Ricard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnanciesJérôme-Philippe Garsi, Martin Schlumberger, Carole Rubino, et al.
Arthritis and Rheumatism|September 25, 2012
Differential expression of junctional adhesion molecules in different stages of systemic sclerosisMirko Manetti, Serena Guiducci, Eloisa Romano, et al.
Clinical and Experimental Rheumatology|March 10, 2011
Microparticles and Kawasaki disease: a marker of vascular damage?Serena Guiducci, Laura Ricci, Eloisa Romano, et al.
The Journal of Clinical Endocrinology and Metabolism|November 13, 2009
Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawalFausto Bogazzi, Clara Giovannetti, Rezene Fessehatsion, et al.
Thyroid : Official Journal of the American Thyroid Association|November 18, 2009
Congenital hypothyroidism and late-onset goiter: identification and characterization of a novel mutation in the sodium/iodide symporter of the proband and family membersLucia Montanelli, Patrizia Agretti, Giuseppina de Marco, et al.
The Journal of Clinical Endocrinology and Metabolism|April 30, 2013
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-upEleonora Molinaro, Carlotta Giani, Laura Agate, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2010
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this questionRossella Elisei, Eleonora Molinaro, Laura Agate, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Annals of the Rheumatic Diseases|May 17, 2011
Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvementMirko Manetti, Serena Guiducci, Claudia Ceccarelli, et al.
Thyroid : Official Journal of the American Thyroid Association|January 13, 2006
RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentrationRossella Elisei, Cristina Romei, Maria Grazia Castagna, et al.
Clinical Endocrinology|March 3, 2009
Health outcomes of children fathered by patients treated with radioiodine for thyroid cancerJérôme-Philippe Garsi, Martin Schlumberger, Marcel Ricard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnanciesJérôme-Philippe Garsi, Martin Schlumberger, Carole Rubino, et al.
Arthritis and Rheumatism|September 25, 2012
Differential expression of junctional adhesion molecules in different stages of systemic sclerosisMirko Manetti, Serena Guiducci, Eloisa Romano, et al.
Clinical and Experimental Rheumatology|March 10, 2011
Microparticles and Kawasaki disease: a marker of vascular damage?Serena Guiducci, Laura Ricci, Eloisa Romano, et al.
The Journal of Clinical Endocrinology and Metabolism|November 13, 2009
Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawalFausto Bogazzi, Clara Giovannetti, Rezene Fessehatsion, et al.
Thyroid : Official Journal of the American Thyroid Association|November 18, 2009
Congenital hypothyroidism and late-onset goiter: identification and characterization of a novel mutation in the sodium/iodide symporter of the proband and family membersLucia Montanelli, Patrizia Agretti, Giuseppina de Marco, et al.
The Journal of Clinical Endocrinology and Metabolism|April 30, 2013
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-upEleonora Molinaro, Carlotta Giani, Laura Agate, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2010
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this questionRossella Elisei, Eleonora Molinaro, Laura Agate, et al.
Pageof 3